Christopher McMaster
Overview
Explore the profile of Christopher McMaster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bird A, McMaster C, Liew D
Arthritis Care Res (Hoboken)
. 2024 Feb;
76(6):904.
PMID: 38317297
No abstract available.
2.
Yang V, McMaster C, Owen C, Leung J, Liu B, Buchanan R, et al.
Lancet Rheumatol
. 2024 Jan;
5(1):e8-e10.
PMID: 38251510
No abstract available.
3.
Yang V, Kragstrup T, McMaster C, Reid P, Singh N, Haysen S, et al.
Drug Saf
. 2023 Jul;
46(11):1049-1071.
PMID: 37490213
Janus kinase inhibitors (JAKi) have enormous appeal as immune-modulating therapies across many chronic inflammatory diseases, but recently this promise has been overshadowed by questions regarding associated cardiovascular and cancer risk...
4.
Shamdasani P, Liew D, Nohrenberg M, Leroi M, McMaster C, Owen C, et al.
Rheumatol Adv Pract
. 2023 Mar;
7(Suppl 1):i12-i18.
PMID: 36968633
Objective: Diagnosing septic arthritis can be challenging and frequently involves clinical assessment, laboratory investigations and synovial fluid analysis. We sought to determine the utility of synovial aspiration and intra-operative synovial...
5.
Bird A, Oakden-Rayner L, McMaster C, Smith L, Zeng M, Wechalekar M, et al.
Arthritis Res Ther
. 2022 Dec;
24(1):268.
PMID: 36510330
Rheumatoid arthritis is an autoimmune condition that predominantly affects the synovial joints, causing joint destruction, pain, and disability. Historically, the standard for measuring the long-term efficacy of disease-modifying antirheumatic drugs...
6.
McMaster C, Chan J, Liew D, Su E, Frauman A, Chapman W, et al.
J Biomed Inform
. 2022 Dec;
137:104265.
PMID: 36464227
The detection of adverse drug reactions (ADRs) is critical to our understanding of the safety and risk-benefit profile of medications. With an incidence that has not changed over the last...
7.
McMaster C, Liew D, Lester S, Rischin A, Black R, Chand V, et al.
Rheumatology (Oxford)
. 2022 Sep;
62(4):1460-1466.
PMID: 36069664
Objectives: To determine COVID-19 vaccine hesitancy rates in inflammatory arthritis patients and identify factors associated with changing vaccine hesitancy over time. Methods: This investigation was a prospective cohort study of...
8.
McMaster C, Bird A, Liew D, Buchanan R, Owen C, Chapman W, et al.
Arthritis Rheumatol
. 2022 Jul;
74(12):1893-1905.
PMID: 35857865
Deep learning has emerged as the leading method in machine learning, spawning a rapidly growing field of academic research and commercial applications across medicine. Deep learning could have particular relevance...
9.
McMaster C, Liew D, Liu B, Schachna L
Rheumatology (Oxford)
. 2022 Apr;
61(10):e316-e317.
PMID: 35416954
No abstract available.
10.
Kragstrup T, Glintborg B, Svensson A, McMaster C, Robinson P, Deleuran B, et al.
RMD Open
. 2022 Feb;
8(1).
PMID: 35197363
The US Food and Drug Administration (FDA) has recently added a new 'black box warning' on all currently approved Janus kinase (JAK) inhibitors indicated for the treatment of arthritis and...